Recurrence Rates of Type I Gastric Neuroendocrine Tumors Treated With Long-acting Somatostatin Analogs

NCT03812939 · clinicaltrials.gov ↗

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Gastric NET

Interventions

DRUG: Octreotide

Sponsor

Peking Union Medical College Hospital